Lymphocytotoxic crossmatch in pediatric living donor liver transplantation

Area of Science:

• Hepatology
• Transplantation Immunology
• Pediatric Surgery

Background:

• Pediatric living donor liver transplantation (LDLT) is a critical treatment for end-stage liver disease.
• The role of pretransplant crossmatch tests (LCT) in selecting living donors for pediatric LDLT remains unclear.
• Immunosuppressive regimens typically involve cyclosporine or FK-based protocols with steroids.

Purpose of the Study:

• To evaluate the association between pretransplant lymphocyte crossmatch test (LCT) results and outcomes in pediatric LDLT.
• To determine if LCT status influences post-transplant complications, rejection rates, and survival.
• To inform donor selection protocols for pediatric LDLT.

Main Methods:

• Retrospective analysis of clinical data from 76 children undergoing 79 LDLTs (May 2001-Jan 2006).
• Patients were stratified into LCT-positive (16.5%) and LCT-negative (83.5%) groups based on pretransplant crossmatch results.
• Comparison of surgical complications, rejection episodes, and patient/graft survival rates between the two groups.

Main Results:

• No significant differences were observed in pretransplant clinical factors between LCT-positive and LCT-negative groups.
• Incidences of vascular and biliary complications, and early or steroid-resistant cellular rejection did not differ significantly.
• One- and three-year patient survival rates were comparable (91.7% vs. 93.5%), as were graft survival rates (92.3% vs. 88.8%).

Conclusions:

• Pretransplant LCT results do not appear to be a significant predictor of outcomes in pediatric LDLT.
• The study suggests that pretransplant LCT may not be necessary for selecting living donors in this population.
• Current findings support a potential shift in donor selection criteria for pediatric LDLT, emphasizing other factors over LCT status.